资讯

Hemostemix to Present Its Clinical Data of the Treatment of Severe Angina

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company ...